InvestorsHub Logo

couldbebetter

11/18/20 6:58 AM

#310240 RE: circuitcity #310235

In answer to your question I would suggest simply contacting BOD members,
especially Dr. Lars Ekman, AMRN's COB. Another suggestion would be to
have an attorney (Marjac?) get two proposals placed on AMRN's Proxy
for a vote:

1. Suggest the company hire an investment bank to sell the company.
2. Suggest the CEO be replaced.

In reality this is unlikely, but what I hope it would lead to is a
dialogue between Marjac and Dr. Ekman to discuss shareholder concerns.
It would, however, help get our message across.

noelan_s09

11/18/20 11:13 AM

#310271 RE: circuitcity #310235

Circuit, you can count me out supporting this. I may be in the minority but I believe there is still significant value in the US. We should have more clarity in the next few months. That along with the ROW and the the future blockbuster drug I would not be in favor of premature sale. JMO

Noel